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OBJECTIVES We sought to investigate the role of endogenous monocyte chemoattractant protein (MCP)-1
in ischemia-induced neovascularization.
BACKGROUND Roles of inflammatory changes including macrophage infiltration are suggested in ischemic
neovascularization.
METHODS Unilateral hindlimb ischemia was induced by excising surgically the entire femoral artery and
vein in mice. Immediately after operation, plasmid deoxyribonucleic acid encoding a
dominant negative mutant of MCP-1 (7ND) or the empty plasmid (mock) was injected into
the ipsilateral thigh adductor muscle.
RESULTS In mock-treated mice, MCP-1 was upregulated transiently in ischemic hindlimb peaking at
day 3. Serial laser Doppler blood flow (LDBF) analysis showed an abrupt decrease in blood
flow, followed by a recovery to the near-normal levels in mock-treated mice; 7ND treatment
had no effects on the initial decrease in LDBF but deteriorated the recovery. At day 3,
macrophage infiltration and inductions of tumor necrosis factor (TNF)-alpha and vascular
endothelial growth factor (VEGF) were prominent in the ischemic adductor muscle in
mock-treated mice; 7ND treatment significantly reduced macrophage infiltration and
suppressed TNF-alpha and VEGF inductions in response to ischemia. At day 21, postmor-
tem angiography and anti-CD31 immunohistostaining revealed well-developed collateral
vessels and capillary formation, respectively, in the ischemic muscle of mock-treated mice;
7ND overexpression remarkably suppressed the collateral vessel formation and capillary
formation.
CONCLUSIONS Endogenous MCP-1 may play a role in ischemia-induced neovascularization by recruiting
macrophages that activate TNF-alpha and VEGF inductions. (J Am Coll Cardiol 2004;44:
661–6) © 2004 by the American College of Cardiology Foundation(
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ihe roles of macrophages have been highlighted in various
ardiovascular diseases, including arteriosclerosis, athero-
clerosis, and myocardial fibrosis (1–3). There is increasing
vidence that inflammatory process is implicated as the
rigger element of neovascularization in response to isch-
mia. Inflammatory cells, especially macrophages, infiltrate
uring the formations of capillaries (angiogenesis) and
ngiographically visible collateral vessels (arteriogenesis) in
he ischemic tissue (4–7). Recently, we have shown that
ngiotensin II-mediated macrophage infiltration precedes
eovascularization in unilateral ischemic hindlimb model,
nd the infiltrated macrophages produce vascular endothe-
ial growth factor (VEGF) in response to ischemia (8). Also,
rras et al. (4) revealed that macrophages are the main
ource of tumor necrosis factor (TNF)-alpha during collat-
ral vessel formation in the rabbit ischemic hindlimb. In
ddition, earlier studies demonstrated that exogenous ad-
inistration of monocyte chemoattractant protein-1
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Manuscript received January 7, 2004; revised manuscript received March 18, 2004,eccepted April 20, 2004.MCP-1), a key molecule for the recruitment of monocytes/
acrophages (9), accelerated ischemia-induced formation
f collateral vessels in the rabbit hindlimb (7,10). Taken
ogether, the possible role of MCP-1 was suggested in
schemia-induced neovascularization by recruiting macro-
hages that, in turn, produce angiogenic growth factors such
s VEGF and TNF-alpha. However, there are no available
ata regarding the specific role of endogenous MCP-1 in
schemia-induced arteriogenesis and angiogenesis.
A mutant of MCP-1, which lacks the N-terminal amino
cids 2 to 8 (7ND), has a potent dominant negative activity
11). A series of recent studies have shown that overexpres-
ion of 7ND is a useful strategy for blocking MCP-1 activity
n vivo in various cardiovascular disease models (12,13). In
he present study, we sought to determine the role of the
ndogenous MCP-1 in ischemia-induced neovasculariza-
ion in mouse hindlimb. For this purpose, effects of blocking
CP-1 activity in the ischemic hindlimb were investigated
y overexpressing 7ND in the ischemic tissue.
ETHODS
uman 7ND complementary deoxyribonucleic acid (DNA)
as constructed by recombinant polymerase chain reaction
sing a wild type MCP-1 complementary DNA and cloned
nto Bam HI (5=) and Not I (3=) site of the pCDNA3
xpression plasmid vector (Invitrogen Corp., Tokyo, Japan),
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MCP-1 and Neovascularization August 4, 2004:661–6s described previously (12). Twenty-four nucleotides en-
oding FLAG epitope were added directly at the 3= termi-
us of 7ND sequence (12). All sequences were confirmed by
ouble-stranded DNA sequencing. The dominant negative
ctivity was verified in vivo as described previously (12).
nimal model and gene transfer. The study protocol was
pproved by the Institutional Animal Care and Treatment
ommittee. After being anesthetized with intraperitoneal
entobarbital (50 mg/kg), the entire left femoral artery and
ein were excised surgically in eight-week-old male
57BL/6 mice (Clea Japan Inc., Tokyo, Japan), as de-
cribed previously (14,15). Immediately after operation, 30
l of saline containing denoted dose of plasmid encoding
ND complementary DNA or the empty plasmid (mock)
as injected into the exposed ipsilateral thigh adductor
uscle. Sham mice underwent the same operational proce-
ure except that the artery and vein were left intact.
Expression of transfected 7ND was determined in the
high adductor muscle on the basis of Western blot analysis
sing an anti-FLAG antibody. After mice were killed by an
verdose of intraperitoneal pentobarbital, the thigh adduc-
or muscle was removed, snap-frozen in liquid nitrogen, and
tored at 80°C until use. The tissue was homogenized by
sing FastPrep homogenizer (ThermoSavant, Holbrook,
ew York), and the tissue protein was extracted, separated
n 10% SDS-PAGE, and subjected to Western blot anal-
sis (16). As shown in Figure 1, 7ND expression was
ransiently observed in the adductor muscle, peaking at days
to 7 and returning to insignificant levels by day 14 after
peration and gene transfer.
aser Doppler blood flow (LDBF) analysis. Hindlimb
lood flow was evaluated serially in each mouse (n  12 per
roup) using a LDBF image analyzer (Moor Instruments,
evon, United Kingdom) before surgery and at postopera-
Abbreviations and Acronyms
DNA  deoxyribonucleic acid
EC  endothelial cell
LDBF  laser Doppler blood flow
MCP-1  monocyte chemoattractant protein-1
TNF  tumor necrosis factor
VEGF  vascular endothelial growth factor
7ND  a dominant negative mutant of MCP-1
lacking the N-terminal amino acids 2 to 8
igure 1. Expression of transfected 7ND in the ischemic adductor muscle.
estern blot analysis using an anti-FLAG M2 monoclonal antibody
howed a transient expression of FLAG-fusion 7ND protein in the muscle.
total of 50 g of the total protein was added in each lane. The similarsesults were obtained from three independent experiments.ive days 3, 7, 14, 21, 28, and 35, as previously described
15). After scanning twice, the average LDBF values in the
schemic and normal (nonischemic) legs were calculated on
he basis of colored histogram pixels. To avoid data varia-
ions raised from ambient light and temperature, relative
hanges in hindlimb blood flow were expressed as the ratio
f the left (ischemic) over right (normal) LDBF.
istologic analysis. After mice were killed with an over-
ose of pentobarbital, the thigh adductor muscle was
xcised, fixed in methanol, embedded in paraffin, and then
ectioned into 5-m slices.
APILLARY DENSITY. Capillary endothelial cells (ECs) were
dentified by immunohistostaining with an anti-CD31
onoclonal antibody (Pharmingen, Franklin Lakes, New
ersey). The number of capillaries was counted and averaged
n 15 random microscopic fields from three independent
ross-sections of the adductor muscle in each animal (n 
2) at day 21, and then capillary density was expressed as the
umber of capillaries per high-power field (400).
ACROPHAGE DENSITY. Infiltrated macrophages were de-
ected immunohistochemically by using an anti-F4/80
onoclonal antibody (Serotec, Raleigh, North Carolina) in
he cross-section of the adductor muscle at day 3. Macro-
hages were counted in 15 random microscopic fields from
hree independent sections of each animal (n  8), and
acrophage density was described as the number of F4/80-
abeled cells per high-power field (400) (8).
issue contents of MCP-1, VEGF, and TNF-alpha. At
enoted day, the thigh adductor muscle (n  8 per group)
as excised, snap-frozen in liquid nitrogen, and stored at
80°C until use. After homogenization by using FastPrep
ThermoSavant), the tissue proteins were extracted, and the
ontents of MCP-1, VEGF, and TNF-alpha were deter-
ined by using a commercially available ELISA kit for
ouse MCP-1, mouse VEGF, and mouse TNF-alpha
R&D System, Minneapolis, Minnesota), respectively, ac-
ording to the manufacturer’s instruction.
ostmortem angiography. At day 21, mice (n  12 per
roup) were killed by injecting intraperitoneally an overdose
f pentobarbital. Postmortem angiography was performed
y injecting 200 l of contrast media through a 26-gauge
oft-tip catheter, which was inserted into the abdominal
orta, at a perfusion pressure of 80 to 90 mm Hg. X-ray
ngiograms were taken using a mammography system
Senographe 500T, GE Medical Systems, Tokyo, Japan),
nd the extent of collateral vessel formation was quantified
y angiographic score, as described previously (8,17).
tatistical analysis. Statistical analysis was adequately per-
ormed by unpaired Student t test or analysis of variance
ollowed by Scheffé’s F test. A value of p  0.05 was
onsidered statistically significant. Angiographic score, cap-
llary density, and macrophage count were evaluated by two
bservers in a blind manner, and the values obtained by the
wo observers were averaged. The interobserver or intraob-
erver variation was 5% in each experiment.
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rrespective of 7ND gene transfer, all mice survived after
urgery of unilateral hindlimb ischemia and looked healthy
uring the observation period. Body weight was similar
mong the study groups over the time course. Also, there
as no significant difference in blood pressure among
ND-treated (up to 300 g) and mock-treated mice (data
ot shown).
ransient MCP-1 expression in ischemic hindlimb. To
etermine the change in endogenous MCP-1 expression,
issue content of MCP-1 was measured in the thigh
dductor muscle. Tissue MCP-1 levels were quite low in
ham mice during the observation period (data not shown).
ndogenous MCP-1 was transiently and remarkably up-
egulated in the ischemic muscle with a peak at day 3,
emaining relatively high at day 7, and returning to the
aseline by day 14 (Fig. 2).
eteriorated recovery of LDBF of ischemic hindlimb by
ND overexpression. In mock-treated mice, serial LDBF
nalysis demonstrated an abrupt decrease in blood flow of
igure 2. Endogenous monocyte chemoattractant protein-1 (MCP-1)
nduction in the ischemic hindlimb. Pooled data of temporal changes in
ndogenous MCP-1 content in the thigh adductor muscle in the ischemic
indlimb (open bars). Solid bars  sham mice. Bar  1  SD (n  8).
igure 3. Laser Doppler blood flow (LDBF) analysis was performed seria
A) Representative LDBF images of the ischemic (arrow heads) and noni
f temporal changes in ischemic/nonischemic LDBF ratio. The recovery
anner. *p  0.05 and **p  0.01 vs. mock-treated mice. Bar  1  SD (n he left ischemic hindlimb, followed by a gradual recovery to
near-normal level by day 35, whereas there were no
hanges in blood flow of the right normal hindlimb (Fig. 3).
n mice with 7ND gene transfer, the severity of the induced
schemia was similar to that in mock-treated mice. How-
ver, 7ND overexpression deteriorated the recovery of the
indlimb blood flow during the observation period, and the
atio of ischemic/normal LDBF was persistently lower in
ND-treated mice compared with mock-treated mice. The
ffects of 7ND were dose-dependent on the amount of the
njected 7ND plasmid, and 200 g of 7ND plasmid was the
inimum dose that induced the maximum inhibitory effect
Fig. 3B). Accordingly, 200 g of 7ND was used in the
ollowing experiments.
ffects of 7ND on macrophage infiltration. Inflamma-
ory cell infiltration and skeletal muscle degeneration were
bserved in the ischemic adductor muscle of mock-treated
ice at day 3 (Fig. 4A). It was apparent that less infiltrated
ells were found in 7ND-treated mice although the extent
f skeletal muscle degeneration was not affected by 7ND
verexpression. The number of F8/40-positive macrophages
ere examined at day 3 when a transient infiltration of
acrophages peaked (8). Macrophage infiltration was re-
arkably reduced by 7ND overexpression to 20% of mock-
reated mice (Fig. 4B). At day 21, irrespective of 7ND
reatment, regeneration of skeletal myocytes was evident,
nd the infiltrated cells were scarcely found in ischemic
uscle.
educed expression of angiogenic factors in 7ND-
reated mice. Ischemia transiently enhanced VEGF ex-
ression in the adductor muscle with a peak at day 3 (Fig.
). At days 3 and 7, 7ND overexpression significantly
each mouse to determine the blood flow in unilateral ischemic hindlimb.
ic hindlimb in 7ND-transfected and mock-treated mice. (B) Pooled data
BF ratio was deteriorated by 7ND overexpression in a dose-dependentlly in
schem
of LD12).
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MCP-1 and Neovascularization August 4, 2004:661–6ecreased the ischemia-induced VEGF induction to the
evels, which were still significantly higher than that of sham
ice.
Tumor necrosis factor-alpha is known as not only an
nflammatory mediator but also a potent inducer of the
schemia-induced arteriogenesis (7). In mock-treated mice,
NF-alpha expression was transiently induced in the ad-
uctor muscle, peaking at day 3. The ischemia-induced
NF-alpha upregulation was remarkably inhibited by 7ND
verexpression at day 3, declining to the sham level at day 7.
igure 4. (A) Representative microphotographs of hematoxylin-eosin–st
ND-treated mice at days 3 and 14. (B, top) Representative immunohisto
ay 3. The serial sections were subjected to the experiments for A (day 3) a
n mock- and 7ND-transfected mice at day 3. Bar  1  SD (n  8).
igure 5. Pooled data demonstrating the effects of 7ND gene transfer on
ascular endothelial growth factor (VEGF) induction and tumor necrosis
actor (TNF)-alpha induction in ischemic thigh adductor muscle at days 3
nd 7. Bar  1  SD (n  8). Solid bars  7ND-transfected mice; open
ars  mock-treated mice; open squares  sham-operated mice without
ny gene transfection. *p 0.05 and **p 0.01 versus sham mice. Analysis
f variance followed by Scheffé’s F test was performed for statisticalpomparison.mpaired neovascularization in 7ND-treated mice. The
evelopment of angiographically visible collateral vessels
nd capillary formation were studied to determine whether
mpaired neovascularization was associated with reduced
DBF in ischemic hindlimb treated with 7ND. First, at day
1, postmortem angiography was performed, and the an-
iographic score was investigated (Fig. 6A). Mock-treated
ice showed well-developed collateral vessels in the isch-
mic hindlimb. The number of collateral vessels was signif-
cantly reduced by overexpressing 7ND, and 7ND decreased
he angiographic score to 60% of mock-treated mice.
Next, capillary density was evaluated for specific evidence
f neovascularization at the microcirculation level (Fig. 6B).
n mock-treated mice, a number of the capillaries sur-
ounded by CD31-positive ECs were found in the adductor
uscle of the ischemic hindlimb at day 21. Overexpression
f 7ND significantly reduced the capillary density in the
schemic muscle to 35% of mock-treated mice. There was
o spatial variation of the distribution of the capillaries in
he ischemic adductor muscles in mock- and 7ND-treated
ice.
ISCUSSION
he present study demonstrated that MCP-1 is transiently
nduced in the ischemic hindlimb of mice, which is the
ell-studied model of ischemia-induced neovascularization
14). Blockade of endogenous MCP-1 activity by 7ND
verexpression remarkably inhibited ischemia-induced mac-
ophage infiltration and significantly reduced VEGF and
NF-alpha inductions in the ischemic tissue in the early
hase. Furthermore, 7ND overexpression significantly im-
sections of ischemic thigh adductor muscle obtained from mock- and
ings for F4/80, a macrophage-specific marker, of the adductor muscles at
. (B, bottom) Pooled data showing the number of infiltrated macrophagesained
stain
nd Baired the recovery of the LDBF reduction associated with
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August 4, 2004:661–6 MCP-1 and Neovascularizationeduced angiographically visible collateral and capillary for-
ations in the ischemic hindlimb in the late phase.
As shown in Figure 2, unilateral hindlimb ischemia induced
transient and remarkable MCP-1 induction in the thigh
dductor muscle, peaking at day 3. It was noteworthy that the
eak of MCP-1 induction coincided with that of macrophage
nfiltration seen in our previous study (8). Thus, we sought to
larify the role of endogenous MCP-1 by overexpressing 7ND,
dominant negative mutant of MCP-1, in the ischemic
dductor muscle, because this mutant can bind to the MCP-1
eceptors on the target cells but does not induce the intracel-
ular signaling activation (11). When complementary DNA
ncoding 7ND was injected into the adductor muscle at the
ime of the surgical removal of femoral artery and vein, a
ransient, yet significant, expression of 7ND protein was
bserved on the basis of Western blotting against the FLAG
pitope tag (Fig. 1). Because transfected 7ND was expressed as
ong as ischemia-induced MCP-1 induction (Fig. 2) was
igure 6. Effects of 7ND overexpression on ischemia-induced neovascu-
arization. (A) Postmortem angiograms at day 21; 7ND overexpression
liminated the development of angiographically visible collateral vessels
top), and angiographic score was significantly lower in 7ND-treated mice
s compared with mock-transfected mice (bottom). Bar  1  SD (n 
2). (B) Capillary density of the thigh adductor muscle at day 21.
mmunohistostaining for CD31, an endothelial cell marker (stained as
rown), was performed to determine the capillaries in the ischemic muscle
top). Capillary density at day 21 was significantly reduced by 7ND gene
ransfer in the ischemic hindlimb (bottom). Bar  1  SD (n  12).resent, it was expected that activity of endogenous MCP-1 rould be blocked in ischemic hindlimb. Indeed, as shown in
igure 4, macrophage infiltration was remarkably inhibited in
he ischemic muscle by 7ND overexpression. This finding
ndicates that MCP-1 is a major determinant of the macro-
hage recruitment into the ischemic hindlimb. Along with
schemic hindlimb, MCP-1 induction was documented in
schemic cerebral cortex (18), ischemia-reperfused heart (19),
schemia-reperfused kidney (20), and ischemic retinopathy
21). The precise mechanism whereby ischemia induces
CP-1 induction remains unknown at present. Activation of
ocal angiotensin II system may be involved in one of the
echanisms, because MCP-1 induction in the ischemic hind-
imb is remarkably attenuated in the angiotensin II type 1
eceptor knockout mice (8).
The present study demonstrated that when MCP-1
ctivity was blocked, inductions of VEGF and TNF-alpha
ere significantly reduced in the ischemic hindlimb (Fig. 5).
he attenuation of VEGF and TNF-alpha inductions could
e responsible for the decreased formation of capillaries and
ngiographically visible collaterals, resulting in deteriorated
ecovery of blood flow of the ischemic hindlimb in 7ND-
reated mice. It is indicated that infiltrated macrophages
ay facilitate ischemia-induced arteriogenesis and angio-
enesis by producing VEGF (8). Moreover, activated mac-
ophages have been shown to predominantly produce TNF-
lpha upon the hindlimb ischemia (4). Tumor necrosis
actor-alpha is a major mediator of inflammatory reactions,
nd also participates in arteriogenesis characterized by the
ormation of angiographically visible collaterals in the isch-
mic hindlimb (4). Because TNF-alpha is responsible for
dhesion and activation of additional macrophages via
pregulation of cell adhesion molecules on both ECs and
acrophages (22,23), the angiogenic properties of TNF-
lpha may be attributable, in part, to the formation of
ositive feedback loop of the macrophage-mediated mech-
nisms. Taken together, inhibition of TNF-alpha induction
ay lead to the elimination of ischemia-induced neovascu-
arization both through the prevention of TNF-alpha–
ediated exaggeration of inflammatory process and through
he attenuation of the angiogenic properties of TNF-alpha.
n addition, it has been shown that ECs express the MCP-1
eceptor CCR2 and that MCP-1 induces proliferation and
igration of ECs (24). Thus, it is also possible that 7ND
verexpression may inhibit the direct angiogenic effect of
CP-1. As shown in Figures 4B and 5, the inhibitory effect
f 7ND on VEGF induction was smaller than those on
acrophage infiltration. Our previous study demonstrated
hat, in addition to inflammatory cells, skeletal myocytes
xpress VEGF in the adductor muscle of the ischemic
indlimb (8). Thus, the skeletal myocytes, which were not
nhibited by 7ND, may be responsible for the 7ND-
nsensitive VEGF production.
It was apparent that the observed effects of 7ND are partial
n the inhibition of ischemia-induced neovascularization, al-
hough macrophage infiltration was almost abolished. The
eduction in LDBF ratio by 7ND was most evident at day 7,
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MCP-1 and Neovascularization August 4, 2004:661–6nd thereafter the extent of the LDBF reduction was smaller in
he later phase. It was possible that inflammatory process was
ctivated after 7ND expression had decayed. However, this
oes not seem the case because there were only sparse inter-
titial cells in the ischemic thigh muscle after day 14, irrespec-
ively of 7ND treatment (Fig. 4). Another possible explanation
s that macrophage-mediated inflammation participates in the
ecovery of LDBF of the ischemic hindlimb, mainly in the
arly phase, as an initiator of ischemic neovascularization.
hus, the 7ND-insensitive neovascularization, especially in the
ater phase, may be dependent upon the mechanisms related to
ells other than macrophages.
At day 21, 7ND overexpression remarkably reduced
ollateral vessel formation and the intramuscular capillary
ormation in the ischemic hindlimb, whereas the inhibitory
ffects on the recovery of LDBF were modest. In the present
tudy, we used an LDBF imaging system that can detect
lood flow of the tissue surface to a depth of 600 m (14),
ndicating that LDBF images reflect mainly the superficial
nd subdermal blood flow and, to lesser extent, the intra-
ural blood flow. This may explain the difference in the
esponse to 7ND between LDBF image and other param-
ters of neovascularization (angiography and histology).
his issue should be addressed in future studies.
tudy limitations. It has been shown that 7ND is not only
xpressed in the transfected site (e.g., thigh muscle) but also
s secreted into the systemic circulation and, in turn, blocks
CP-1 activity in the remote organ (12,13). Thus, we do
ot exclude the possibility that mobilization of endothelial
rogenitor cells from bone marrow is reduced by 7ND
verexpression in ischemic hindlimb.
In conclusion, neovascularization and blood flow recovery in
esponse to hindlimb ischemia were significantly impaired in
ice with functional blockade of MCP-1 activity. Thus, it is
ndicated that the induction of endogenous MCP-1 partici-
ates in angiogenesis and arteriogenesis by recruiting macro-
hages into the ischemic tissue. The present study would
rovide an insight into better understanding of the underlying
echanism of ischemia-induced neovascularization.
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